| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |